Marzia Salvucci

Drug resistance and BCR‐ABL kinase domain mutations in Philadelphia chromosome–positive acute lymphoblastic leukemia from the imatinib to the second‐generation tyrosine kinase inhibitor era: The main changes are in the type of mutations, but not in the frequency of mutation involvement

Simona Soverini, Caterina De Benedittis, Cristina Papayannidis et al. · Cancer · 2013 · 143 citations · Full text

Medicine, Hematology, Oncology +16

Primary intestinal lymphoma: clinical and therapeutic features of 32 patients.

Pier Luigi Zinzani, Massimo Magagnoli, G Pagliani et al. · PubMed · 1997 · 127 citations

Medicine, Oncology, Surgery +13

Investigating factors associated with adherence behaviour in patients with chronic myeloid leukemia: an observational patient-centered outcome study

Fabio Efficace, Michele Baccarani, Gianantonio Rosti et al. · British Journal of Cancer · 2012 · 113 citations · Full text

Pharmacy, Health Behavior, Behavioral Health +15

Differences among young adults, adults and elderly chronic myeloid leukemia patients

Fabio Castagnetti, Gabriele Gugliotta, Michele Baccarani et al. · Annals of Oncology · 2014 · 99 citations · Full text

Medicine, Geriatric Medicine, Oncology +10

Prospective assessment of NGS-detectable mutations in CML patients with nonoptimal response: the NEXT-in-CML study

Simona Soverini, Luana Bavaro, Caterina De Benedittis et al. · Blood · 2019 · 99 citations · Full text

Life Sciences, Genetics, Hematology +13